Literature DB >> 11505450

Plasma concentrations of sVCAM-1 and severity of dengue infections.

B Murgue1, O Cassar, X Deparis.   

Abstract

Adhesion molecules are essential for the immune response. They are involved in the regulation of cell-to-cell contact, thereby enabling leukocytes to communicate. Circulating forms of adhesion molecules are found in the serum of healthy individuals. Raised levels have been associated with disease severity in HCV and other infections and thus appear to be good markers of endothelial damage. The levels of soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and of sP and sL-selectin in the plasma of children hospitalised for dengue in French Polynesia were monitored. Studies from the 1996/1997 dengue-2 outbreak, showed that levels of sVCAM-1 increase steadily during the febrile period, peak on day 7, and then decline relatively rapidly. Disregarding the time frame within the febrile period, sVCAM-1 levels were always higher compared to controls. There was a significant association between sVCAM-1 levels and dengue haemorrhagic fever, a severe manifestation of dengue virus infection characterised by plasma leakage. No association was apparent between sVCAM-1 levels and primary vs. secondary dengue virus infections. Levels of sP-selectin and sL-selectin were significantly higher in primary compared with secondary infection but were not different in patients presenting with plasma leakage. Lastly, sVCAM-1 levels were significantly higher in an outbreak of severe disease in 1989/1990 (dengue-3) when compared to a non-severe outbreak in 1988/1989 (dengue-1) and a mild outbreak in 1996/1997 (dengue-2). The results suggested that levels of sVCAM-1 production might prove to be a useful marker in the management of severe dengue. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505450

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

1.  Dengue virus infection of mast cells triggers endothelial cell activation.

Authors:  Michael G Brown; Laura L Hermann; Andrew C Issekutz; Jean S Marshall; Derek Rowter; Ayham Al-Afif; Robert Anderson
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  Discovery and characterization of potential prognostic biomarkers for dengue hemorrhagic fever.

Authors:  B Katherine Poole-Smith; Alexa Gilbert; Andrea L Gonzalez; Manuela Beltran; Kay M Tomashek; Brian J Ward; Elizabeth A Hunsperger; Momar Ndao
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

3.  Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction.

Authors:  Natthanej Luplertlop; Natthanej Luplerdlop; Dorothée Missé; Dorothy Bray; Virginie Deleuze; Jean-Paul Gonzalez; Vijittra Leardkamolkarn; Hans Yssel; Francisco Veas
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

4.  Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

Authors:  P Koraka; C Suharti; T E Setiati; A T Mairuhu; E Van Gorp; C E Hack; M Juffrie; J Sutaryo; G M Van Der Meer; J Groen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections.

Authors:  M Saito; K Oishi; S Inoue; E M Dimaano; M T P Alera; A M P Robles; B D Estrella; A Kumatori; K Moji; M T Alonzo; C C Buerano; R R Matias; K Morita; F F Natividad; T Nagatake
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

6.  Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells.

Authors:  Rajas V Warke; Kris Xhaja; Katherine J Martin; Marcia F Fournier; Sunil K Shaw; Nathaly Brizuela; Norma de Bosch; David Lapointe; Francis A Ennis; Alan L Rothman; Irene Bosch
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 7.  Dengue virus pathogenesis: an integrated view.

Authors:  Byron E E Martina; Penelope Koraka; Albert D M E Osterhaus
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  American genotype structures decrease dengue virus output from human monocytes and dendritic cells.

Authors:  Raymond Cologna; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 9.  Cardiovascular manifestations of the emerging dengue pandemic.

Authors:  Sophie Yacoub; Heiman Wertheim; Cameron P Simmons; Gavin Screaton; Bridget Wills
Journal:  Nat Rev Cardiol       Date:  2014-04-08       Impact factor: 32.419

10.  Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults.

Authors:  Baolin Liao; Yangbo Tang; Fengyu Hu; Weize Zhou; Xian Yao; Wenxin Hong; Jian Wang; Xiayi Zhang; Xiaoping Tang; Fuchun Zhang
Journal:  Emerg Microbes Infect       Date:  2015-04-22       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.